Matthew Palmer, OD
Optometrist · Mesa, AZNPI 1093970931
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 356 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 356 payments — averaging $23.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$1K
- Dompe US, Inc.$983
- Alcon$827
- Mallinckrodt Hospital Products Inc.$722
- AbbVie$653
- Bausch & Lomb Americas Inc.$479
- plus $3K from 19 others
What the payments were for
- Speaking & faculty fees$3604%
- Food & beverage$7,80195%
- Education$320%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 59 | $1,247 |
| Dompe US, Inc. | 30 | $983 |
| Alcon | 28 | $827 |
| Mallinckrodt Hospital Products Inc. | 35 | $722 |
| AbbVie(2 entities) | 41 | $653 |
| Bausch & Lomb Americas Inc. | 25 | $479 |
| Tarsus Pharmaceuticals, Inc. | 18 | $425 |
| Novartis | 21 | $407 |
| ANI Pharmaceuticals, Inc. | 20 | $404 |
| Coopervision Inc. | 2 | $384 |
| Mallinckrodt Enterprises LLC | 18 | $277 |
| Oyster Point Pharma, Inc. | 10 | $212 |
| Sight Sciences, Inc. | 3 | $205 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $147 |
| Shire North American Group Inc | 10 | $146 |
| Harrow Eye, LLC | 5 | $131 |
| Johnson & Johnson Vision Care, Inc. | 1 | $113 |
| Kala Pharmaceuticals, Inc. | 5 | $106 |
| Biotissue Holdings Inc. | 4 | $78 |
| Aerie Pharmaceuticals, Inc. | 4 | $75 |
| Thea Pharma Inc. | 4 | $68 |
| Eyevance Pharmaceuticals LLC | 2 | $33 |
| Glaukos Corporation | 1 | $33 |
| Ivantis, Inc | 1 | $22 |
| Amgen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNI(R) SURGICAL SYSTEM (US)$143
- Hydrus Microstent$122
- Acuvue$113
- Clareon$106
How this compares
$8,192 in reported general payments places this provider in the 95th percentile of 1,134 optometrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxervateCenegermin-Bkbj | 25 | $1,410,957 |
| RestasisCyclosporine | 186 | $248,154 |
| LumiganBimatoprost | 118 | $69,989 |
| XiidraLifitegrast | 44 | $63,720 |
| XdemvyLotilaner | 27 | $50,010 |
| CequaCyclosporine | 25 | $31,789 |
| TyrvayaVarenicline Tartrate | 42 | $27,571 |
| AlrexLoteprednol Etabonate | 57 | $18,664 |
| EysuvisLoteprednol Etabonate | 17 | $13,145 |
| Prednisolone Acetate | 375 | $12,007 |
| ZyletTobramycin/Lotepred Etab | 30 | $10,256 |
| Alphagan PBrimonidine Tartrate | 22 | $10,126 |
| Cyclosporine | 14 | $8,673 |
| CombiganBrimonidine Tartrate/Timolol | 17 | $8,511 |
| RhopressaNetarsudil Mesylate | 14 | $8,386 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dompe US, Inc.Oxervate | $983 | $1,410,95725 claims |
| AbbVieRestasis, Lumigan, Alphagan P, Combigan | $653 | $336,780343 claims |
| Bausch & Lomb Americas Inc.Xiidra | $479 | $63,72044 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $425 | $50,01027 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCAlrex, Zylet, Loteprednol Etabonate | $147 | $34,767129 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $1,247 | $31,78925 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $212 | $27,57142 claims |
| Kala Pharmaceuticals, Inc.Eysuvis | $106 | $13,14517 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa | $75 | $8,38614 claims |
| Eyevance Pharmaceuticals LLCFlarex | $33 | $2,13315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,134 optometrist providers in Arizona.
Other optometrist in Mesa
- Kerry PearsonMesa$10K
- Frank AkersMesa$7K
- Marc BloomensteinScottsdale$1.4M
- Stephanie WooLake Havasu City$538K
- Jashpal RajasansiGilbert$104K
- Jamie KuhnGlendale$37K
- Tania SobchukLake Havasu City$32K
- Stephen CohenScottsdale$32K
- Andrew ZagelbaumScottsdale$25K
- Linda TrinhPeoria$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.